Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Crunch time for peer review in lawsuit

Nature volume 452, pages 6–7 (2008)Cite this article

Ruling imminent on Pfizer's challenge to journal confidentiality.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author inPubMed Google Scholar

Related links

Related links

Related links in Nature Research

Cardiovascular medicine

Pharmacology

Related external links

The New England Journal of Medicine

Pfizer

Science Editorial, 22 February 2008

US District court, Massachusetts

Clinicaltrials.gov description of ongoing Pfizer-sponsored Celebrex/naproxen/ibuprofen trial

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Crunch time for peer review in lawsuit. Nature 452, 6–7 (2008). https://doi.org/10.1038/452006a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/452006a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing